Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Relationship between depression and medication adherence in cardiovascular disease: the perfect challenge for the integrated care team.

Goldstein CM, Gathright EC, Garcia S.

Patient Prefer Adherence. 2017 Mar 15;11:547-559. doi: 10.2147/PPA.S127277. eCollection 2017. Review.

2.

The Techniques for Overcoming Depression Questionnaire: Mokken Scale Analysis, Reliability, and Concurrent Validity in Depressed Cardiac Patients.

Freedland KE, Lemos M, Doyle F, Steinmeyer BC, Csik I, Carney RM.

Cognit Ther Res. 2017 Feb;41(1):117-129. doi: 10.1007/s10608-016-9797-6. Epub 2016 Aug 17.

PMID:
28239215
3.

Trajectories of depressive symptoms after a major cardiac event.

Mittag O, Kampling H, Farin E, Tully PJ.

Health Psychol Open. 2016 Jan 12;3(1):2055102915624873. doi: 10.1177/2055102915624873. eCollection 2016 Jan.

4.

The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy.

Shively CA, Silverstein-Metzler M, Justice J, Willard SL.

Neurosci Biobehav Rev. 2017 Mar;74(Pt B):433-443. doi: 10.1016/j.neubiorev.2016.08.037. Epub 2016 Aug 30. Review.

PMID:
27590831
5.

Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.

MacQueen G, Santaguida P, Keshavarz H, Jaworska N, Levine M, Beyene J, Raina P.

Can J Psychiatry. 2017 Jan;62(1):11-23. doi: 10.1177/0706743716664885. Epub 2016 Sep 24.

PMID:
27554483
6.

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial.

Mazereeuw G, Herrmann N, Oh PI, Ma DW, Wang CT, Kiss A, Lanctôt KL.

J Clin Psychopharmacol. 2016 Oct;36(5):436-44. doi: 10.1097/JCP.0000000000000565.

7.

Ecological Momentary Assessments and Automated Time Series Analysis to Promote Tailored Health Care: A Proof-of-Principle Study.

van der Krieke L, Emerencia AC, Bos EH, Rosmalen JG, Riese H, Aiello M, Sytema S, de Jonge P.

JMIR Res Protoc. 2015 Aug 7;4(3):e100. doi: 10.2196/resprot.4000.

8.

Glycemia, Diabetes Status, and Cognition in Hispanic Adults Aged 55-64 Years.

Luchsinger JA, Cabral R, Eimicke JP, Manly JJ, Teresi J.

Psychosom Med. 2015 Jul-Aug;77(6):653-63. doi: 10.1097/PSY.0000000000000208.

9.

Panic disorder and incident coronary heart disease: a systematic review and meta-analysis protocol.

Tully PJ, Wittert GA, Turnbull DA, Beltrame JF, Horowitz JD, Cosh S, Baumeister H.

Syst Rev. 2015 Mar 25;4:33. doi: 10.1186/s13643-015-0026-2. Review.

10.

Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.

Shively CA, Register TC, Appt SE, Clarkson TB.

Psychosom Med. 2015 Apr;77(3):267-78. doi: 10.1097/PSY.0000000000000163.

11.

Optimism and recovery after acute coronary syndrome: a clinical cohort study.

Ronaldson A, Molloy GJ, Wikman A, Poole L, Kaski JC, Steptoe A.

Psychosom Med. 2015 Apr;77(3):311-8. doi: 10.1097/PSY.0000000000000155.

12.

Correlates and Escitalopram Treatment Effects on Sleep Disturbance in Patients with Acute Coronary Syndrome: K-DEPACS and EsDEPACS.

Kim JM, Stewart R, Bae KY, Kang HJ, Kim SW, Shin IS, Hong YJ, Ahn Y, Jeong MH, Yoon JS.

Sleep. 2015 Jul 1;38(7):1105-11. doi: 10.5665/sleep.4822.

13.

Leukocyte ß-adrenergic receptor sensitivity and depression severity in patients with heart failure.

Redwine LS, Hong S, Rutledge T, Wentworth B, Pung M, Ziegler MG, Maisel A, Greenberg B, Mills PJ.

Psychosom Med. 2014 Nov-Dec;76(9):726-31. doi: 10.1097/PSY.0000000000000119.

14.

Assessment of patient-reported symptoms of anxiety.

Rose M, Devine J.

Dialogues Clin Neurosci. 2014 Jun;16(2):197-211. Review.

15.

Depression in primary care patients with coronary heart disease: baseline findings from the UPBEAT UK study.

Walters P, Barley EA, Mann A, Phillips R, Tylee A.

PLoS One. 2014 Jun 12;9(6):e98342. doi: 10.1371/journal.pone.0098342. eCollection 2014.

16.

The UPBEAT nurse-delivered personalized care intervention for people with coronary heart disease who report current chest pain and depression: a randomised controlled pilot study.

Barley EA, Walters P, Haddad M, Phillips R, Achilla E, McCrone P, Van Marwijk H, Mann A, Tylee A.

PLoS One. 2014 Jun 5;9(6):e98704. doi: 10.1371/journal.pone.0098704. eCollection 2014.

17.

Using a patient-generated mental-health measure 'PSYCHLOPS' to explore problems in patients with coronary heart disease.

Lawton R, Seed PT, Kordowicz M, Schofield P, Tylee A, Ashworth M.

Br J Gen Pract. 2014 Jun;64(623):e354-63. doi: 10.3399/bjgp14X680137.

18.

Assessing depression in cardiac patients: what measures should be considered?

Ceccarini M, Manzoni GM, Castelnuovo G.

Depress Res Treat. 2014;2014:148256. doi: 10.1155/2014/148256. Epub 2014 Feb 6. Review.

19.

Design and Methodology for the Korean Observational and Escitalopram Treatment Studies of Depression in Acute Coronary Syndrome: K-DEPACS and EsDEPACS.

Kim JM, Bae KY, Kang HJ, Kim SW, Shin IS, Hong YJ, Kim JH, Shin HY, Ahn Y, Kim JK, Jeong MH, Yoon JS.

Psychiatry Investig. 2014 Jan;11(1):89-94. doi: 10.4306/pi.2014.11.1.89. Epub 2014 Jan 21.

20.

Depression as a risk factor for adverse outcomes in coronary heart disease.

Freedland KE, Carney RM.

BMC Med. 2013 May 15;11:131. doi: 10.1186/1741-7015-11-131.

Supplemental Content

Support Center